Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
NT-VRL
- Development stage
- Preclinical
- Lead developer
- Eybna
- Modality
- Small Molecules
- Administration
- Inhalation
01
Overview
NT-VRL is a proprietary terpene-based botanical formulation developed by Eybna for anti-inflammatory and antiviral applications. It is described as a patented, data-driven blend of approximately 30 natural terpenes found in cannabis and other plants, with major constituents including beta caryophyllene, eucalyptol, and citral. In vitro, the formulation showed dose-dependent inhibition of pro-inflammatory cytokine secretion without compromising cell viability, and demonstrated antiviral activity against human coronavirus 229E in human lung fibroblasts. The reported antiviral mechanism is prevention of viral attachment and or entry, and activity was reported to be enhanced when NT-VRL was combined with cannabidiol. The program appears to be in preclinical development for inflammation including cytokine storm and for viral respiratory infections.
- Brand names
- NT-VRL
- Other names
- NT-VRL terpene formulation
Beyond the preview
Go deeper on NT-VRL.
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Indications & development
Full profile accessExplore development by indication, patient population, and geography.
- Indications
- Development status
- Countries
Licensing & deals
Full profile accessTrace asset ownership, licensing agreements, and commercial partnerships.
- Partners
- Deal terms
- Milestones
Patents & exclusivity
Full profile accessExplore the patent landscape and regulatory exclusivity around an asset.
- Patents
- Expiration dates
- Exclusivity
Competitive landscape
Full profile accessCompare development programs by target, modality, and indication.
- Competing assets
- Targets
- Development stage
Research & analysis
Full profile accessConnect source evidence and development news to your research questions.
- Publications
- News
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on NT-VRL.